Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus ; volume:7 ; number:1 ; day:21 ; month:10 ; year:2022 ; pages:1-9 ; date:12.2022
npj vaccines ; 7, Heft 1 (21.10.2022), 1-9, 12.2022
- Creator
-
Jhajharia, Saket
Lai, Fritz
Low, Heng Boon
Purushotorman, Kiren
Shunmuganathan, Bhuvaneshwari D/O
Chan, Conrad En Zuo
Hammond, Rachel
Netter, Hans-Jürgen
Chen, Qingfeng
Lim, Seng Gee
MacAry, Paul A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-022-00516-7
- URN
-
urn:nbn:de:101:1-2023010709052258881657
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jhajharia, Saket
- Lai, Fritz
- Low, Heng Boon
- Purushotorman, Kiren
- Shunmuganathan, Bhuvaneshwari D/O
- Chan, Conrad En Zuo
- Hammond, Rachel
- Netter, Hans-Jürgen
- Chen, Qingfeng
- Lim, Seng Gee
- MacAry, Paul A.
- SpringerLink (Online service)
Other Objects (12)
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
Neutralizing Antibody Validation Testing and Reporting Harmonization
Neutralizing Antibody Sample Testing and Report Harmonization
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Neutralizing antibody titres in SARS-CoV-2 infections
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Identification of a novel broadly neutralizing antibody targeting HIV-1
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Specificity and overlap in gene segment-defined antibody repertoires
Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
Neutralizing Antibody Validation Testing and Reporting Harmonization
Neutralizing Antibody Sample Testing and Report Harmonization
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Neutralizing antibody titres in SARS-CoV-2 infections
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Identification of a novel broadly neutralizing antibody targeting HIV-1
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Specificity and overlap in gene segment-defined antibody repertoires
Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
Neutralizing Antibody Validation Testing and Reporting Harmonization
Neutralizing Antibody Sample Testing and Report Harmonization
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Neutralizing antibody titres in SARS-CoV-2 infections
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Identification of a novel broadly neutralizing antibody targeting HIV-1
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Specificity and overlap in gene segment-defined antibody repertoires
Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody